Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss of $0.14/Share
Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q1 EPS of ($0.14), versus ($0.18) reported last year.
For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.
